Report Detail
Global Research Grade Antibodies Market Growth (Status and Outlook) 2022-2028
- RnM4495455 |
- 23 November, 2022 |
- Global |
- 122 Pages |
- LPI(LP Information) |
- Medical Devices & Consumables
An antibody (also known as an immunoglobulin) is a protective protein produced by the immune system in response to the presence of an antigen. It is a Y-shaped molecule composed of two heavy chains and two light chains, which are held together by disulfide bonds. Each tip of its Y-shaped structure contains a paratope that can specifically bind with an epitope on a corresponding antigen. The antibodies can be then used in a multitude of applications, including but not limited to: western blot (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry (IHC), chromatin immunoprecipitation (ChIP), and flow cytometry (FC). As a cornerstone of the body’s immune response, antibodies can provide significant data to support scientists’ research.
The global market for Research Grade Antibodies is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
The APAC Research Grade Antibodies market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The United States Research Grade Antibodies market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The Europe Research Grade Antibodies market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The China Research Grade Antibodies market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
Global key Research Grade Antibodies players cover Abcam, Merck, CST, Thermo Fisher and R&D Systems, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
Report Coverage
This latest report provides a deep insight into the global Research Grade Antibodies market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.
This report aims to provide a comprehensive picture of the global Research Grade Antibodies market, with both quantitative and qualitative data, to help readers understand how the Research Grade Antibodies market scenario changed across the globe during the pandemic and Russia-Ukraine War.
The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions.
Market Segmentation:
The study segments the Research Grade Antibodies market and forecasts the market size by Type (Monoclonal Antibodies and Polyclonal Antibodies,), by End User (Pharmaceutical & Biotechnology Companies, CRO/CDMO Companies, Academic & Research Institutes and Others), and region (APAC, Americas, Europe, and Middle East & Africa).
Segmentation by type
Monoclonal Antibodies
Polyclonal Antibodies
Segmentation by end user
Pharmaceutical & Biotechnology Companies
CRO/CDMO Companies
Academic & Research Institutes
Others
Segmentation by region
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Major companies covered
Abcam
Merck
CST
Thermo Fisher
R&D Systems
BD
Biolegend
Proteintech
ABclonal
Bio-Rad
Santa Cruz Biotechnology (SCBT)
Novus Biologicals
Genetex
Abnova
Abcepta
Aviva Biosciences
MBL
BioXCell
Sino Biological
HuaBio
Chapter Introduction
Chapter 1: Scope of Research Grade Antibodies, Research Methodology, etc.
Chapter 2: Executive Summary, global Research Grade Antibodies market size and CAGR, Research Grade Antibodies market size by region, by type, by end user, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Research Grade Antibodies revenue, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Research Grade Antibodies revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, revenue segment by country, by type, and end user.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Research Grade Antibodies market size forecast by region, by country, by type, and end user
Chapter 13: Comprehensive company profiles of the leading players, including Abcam, Merck, CST, Thermo Fisher, R&D Systems, BD, Biolegend, Proteintech and ABclonal, etc.
Chapter 14: Research Findings and Conclusion
1 Scope of the Report
- 1.1 Market Introduction
- 1.2 Years Considered
- 1.3 Research Objectives
- 1.4 Market Research Methodology
- 1.5 Research Process and Data Source
- 1.6 Economic Indicators
- 1.7 Currency Considered
2 Executive Summary
- 2.1 World Market Overview
- 2.1.1 Global Research Grade Antibodies Market Size 2017-2028
- 2.1.2 Research Grade Antibodies Market Size CAGR by Region 2017 VS 2022 VS 2028
- 2.2 Research Grade Antibodies Segment by Type
- 2.2.1 Monoclonal Antibodies
- 2.2.2 Polyclonal Antibodies
- 2.3 Research Grade Antibodies Market Size by Type
- 2.3.1 Research Grade Antibodies Market Size CAGR by Type (2017 VS 2022 VS 2028)
- 2.3.2 Global Research Grade Antibodies Market Size Market Share by Type (2017-2022)
- 2.4 Research Grade Antibodies Segment by End User
- 2.4.1 Pharmaceutical & Biotechnology Companies
- 2.4.2 CRO/CDMO Companies
- 2.4.3 Academic & Research Institutes
- 2.4.4 Others
- 2.5 Research Grade Antibodies Market Size by End User
- 2.5.1 Research Grade Antibodies Market Size CAGR by End User (2017 VS 2022 VS 2028)
- 2.5.2 Global Research Grade Antibodies Market Size Market Share by End User (2017-2022)
3 Research Grade Antibodies Market Size by Player
- 3.1 Research Grade Antibodies Market Size Market Share by Players
- 3.1.1 Global Research Grade Antibodies Revenue by Players (2020-2022)
- 3.1.2 Global Research Grade Antibodies Revenue Market Share by Players (2020-2022)
- 3.2 Global Research Grade Antibodies Key Players Head office and Products Offered
- 3.3 Market Concentration Rate Analysis
- 3.3.1 Competition Landscape Analysis
- 3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
- 3.4 New Products and Potential Entrants
- 3.5 Mergers & Acquisitions, Expansion
4 Research Grade Antibodies by Regions
- 4.1 Research Grade Antibodies Market Size by Regions (2017-2022)
- 4.2 Americas Research Grade Antibodies Market Size Growth (2017-2022)
- 4.3 APAC Research Grade Antibodies Market Size Growth (2017-2022)
- 4.4 Europe Research Grade Antibodies Market Size Growth (2017-2022)
- 4.5 Middle East & Africa Research Grade Antibodies Market Size Growth (2017-2022)
5 Americas
- 5.1 Americas Research Grade Antibodies Market Size by Country (2017-2022)
- 5.2 Americas Research Grade Antibodies Market Size by Type (2017-2022)
- 5.3 Americas Research Grade Antibodies Market Size by End User (2017-2022)
- 5.4 United States
- 5.5 Canada
- 5.6 Mexico
- 5.7 Brazil
6 APAC
- 6.1 APAC Research Grade Antibodies Market Size by Region (2017-2022)
- 6.2 APAC Research Grade Antibodies Market Size by Type (2017-2022)
- 6.3 APAC Research Grade Antibodies Market Size by End User (2017-2022)
- 6.4 China
- 6.5 Japan
- 6.6 Korea
- 6.7 Southeast Asia
- 6.8 India
- 6.9 Australia
7 Europe
- 7.1 Europe Research Grade Antibodies by Country (2017-2022)
- 7.2 Europe Research Grade Antibodies Market Size by Type (2017-2022)
- 7.3 Europe Research Grade Antibodies Market Size by End User (2017-2022)
- 7.4 Germany
- 7.5 France
- 7.6 UK
- 7.7 Italy
- 7.8 Russia
8 Middle East & Africa
- 8.1 Middle East & Africa Research Grade Antibodies by Region (2017-2022)
- 8.2 Middle East & Africa Research Grade Antibodies Market Size by Type (2017-2022)
- 8.3 Middle East & Africa Research Grade Antibodies Market Size by End User (2017-2022)
- 8.4 Egypt
- 8.5 South Africa
- 8.6 Israel
- 8.7 Turkey
- 8.8 GCC Countries
9 Market Drivers, Challenges and Trends
- 9.1 Market Drivers & Growth Opportunities
- 9.2 Market Challenges & Risks
- 9.3 Industry Trends
10 Global Research Grade Antibodies Market Forecast
- 10.1 Global Research Grade Antibodies Forecast by Regions (2023-2028)
- 10.1.1 Global Research Grade Antibodies Forecast by Regions (2023-2028)
- 10.1.2 Americas Research Grade Antibodies Forecast
- 10.1.3 APAC Research Grade Antibodies Forecast
- 10.1.4 Europe Research Grade Antibodies Forecast
- 10.1.5 Middle East & Africa Research Grade Antibodies Forecast
- 10.2 Americas Research Grade Antibodies Forecast by Country (2023-2028)
- 10.2.1 United States Research Grade Antibodies Market Forecast
- 10.2.2 Canada Research Grade Antibodies Market Forecast
- 10.2.3 Mexico Research Grade Antibodies Market Forecast
- 10.2.4 Brazil Research Grade Antibodies Market Forecast
- 10.3 APAC Research Grade Antibodies Forecast by Region (2023-2028)
- 10.3.1 China Research Grade Antibodies Market Forecast
- 10.3.2 Japan Research Grade Antibodies Market Forecast
- 10.3.3 Korea Research Grade Antibodies Market Forecast
- 10.3.4 Southeast Asia Research Grade Antibodies Market Forecast
- 10.3.5 India Research Grade Antibodies Market Forecast
- 10.3.6 Australia Research Grade Antibodies Market Forecast
- 10.4 Europe Research Grade Antibodies Forecast by Country (2023-2028)
- 10.4.1 Germany Research Grade Antibodies Market Forecast
- 10.4.2 France Research Grade Antibodies Market Forecast
- 10.4.3 UK Research Grade Antibodies Market Forecast
- 10.4.4 Italy Research Grade Antibodies Market Forecast
- 10.4.5 Russia Research Grade Antibodies Market Forecast
- 10.5 Middle East & Africa Research Grade Antibodies Forecast by Region (2023-2028)
- 10.5.1 Egypt Research Grade Antibodies Market Forecast
- 10.5.2 South Africa Research Grade Antibodies Market Forecast
- 10.5.3 Israel Research Grade Antibodies Market Forecast
- 10.5.4 Turkey Research Grade Antibodies Market Forecast
- 10.5.5 GCC Countries Research Grade Antibodies Market Forecast
- 10.6 Global Research Grade Antibodies Forecast by Type (2023-2028)
- 10.7 Global Research Grade Antibodies Forecast by End User (2023-2028)
11 Key Players Analysis
- 11.1 Abcam
- 11.1.1 Abcam Company Information
- 11.1.2 Abcam Research Grade Antibodies Product Offered
- 11.1.3 Abcam Research Grade Antibodies Revenue, Gross Margin and Market Share (2020-2022)
- 11.1.4 Abcam Main Business Overview
- 11.1.5 Abcam Latest Developments
- 11.2 Merck
- 11.2.1 Merck Company Information
- 11.2.2 Merck Research Grade Antibodies Product Offered
- 11.2.3 Merck Research Grade Antibodies Revenue, Gross Margin and Market Share (2020-2022)
- 11.2.4 Merck Main Business Overview
- 11.2.5 Merck Latest Developments
- 11.3 CST
- 11.3.1 CST Company Information
- 11.3.2 CST Research Grade Antibodies Product Offered
- 11.3.3 CST Research Grade Antibodies Revenue, Gross Margin and Market Share (2020-2022)
- 11.3.4 CST Main Business Overview
- 11.3.5 CST Latest Developments
- 11.4 Thermo Fisher
- 11.4.1 Thermo Fisher Company Information
- 11.4.2 Thermo Fisher Research Grade Antibodies Product Offered
- 11.4.3 Thermo Fisher Research Grade Antibodies Revenue, Gross Margin and Market Share (2020-2022)
- 11.4.4 Thermo Fisher Main Business Overview
- 11.4.5 Thermo Fisher Latest Developments
- 11.5 R&D Systems
- 11.5.1 R&D Systems Company Information
- 11.5.2 R&D Systems Research Grade Antibodies Product Offered
- 11.5.3 R&D Systems Research Grade Antibodies Revenue, Gross Margin and Market Share (2020-2022)
- 11.5.4 R&D Systems Main Business Overview
- 11.5.5 R&D Systems Latest Developments
- 11.6 BD
- 11.6.1 BD Company Information
- 11.6.2 BD Research Grade Antibodies Product Offered
- 11.6.3 BD Research Grade Antibodies Revenue, Gross Margin and Market Share (2020-2022)
- 11.6.4 BD Main Business Overview
- 11.6.5 BD Latest Developments
- 11.7 Biolegend
- 11.7.1 Biolegend Company Information
- 11.7.2 Biolegend Research Grade Antibodies Product Offered
- 11.7.3 Biolegend Research Grade Antibodies Revenue, Gross Margin and Market Share (2020-2022)
- 11.7.4 Biolegend Main Business Overview
- 11.7.5 Biolegend Latest Developments
- 11.8 Proteintech
- 11.8.1 Proteintech Company Information
- 11.8.2 Proteintech Research Grade Antibodies Product Offered
- 11.8.3 Proteintech Research Grade Antibodies Revenue, Gross Margin and Market Share (2020-2022)
- 11.8.4 Proteintech Main Business Overview
- 11.8.5 Proteintech Latest Developments
- 11.9 ABclonal
- 11.9.1 ABclonal Company Information
- 11.9.2 ABclonal Research Grade Antibodies Product Offered
- 11.9.3 ABclonal Research Grade Antibodies Revenue, Gross Margin and Market Share (2020-2022)
- 11.9.4 ABclonal Main Business Overview
- 11.9.5 ABclonal Latest Developments
- 11.10 Bio-Rad
- 11.10.1 Bio-Rad Company Information
- 11.10.2 Bio-Rad Research Grade Antibodies Product Offered
- 11.10.3 Bio-Rad Research Grade Antibodies Revenue, Gross Margin and Market Share (2020-2022)
- 11.10.4 Bio-Rad Main Business Overview
- 11.10.5 Bio-Rad Latest Developments
- 11.11 Santa Cruz Biotechnology (SCBT)
- 11.11.1 Santa Cruz Biotechnology (SCBT) Company Information
- 11.11.2 Santa Cruz Biotechnology (SCBT) Research Grade Antibodies Product Offered
- 11.11.3 Santa Cruz Biotechnology (SCBT) Research Grade Antibodies Revenue, Gross Margin and Market Share (2020-2022)
- 11.11.4 Santa Cruz Biotechnology (SCBT) Main Business Overview
- 11.11.5 Santa Cruz Biotechnology (SCBT) Latest Developments
- 11.12 Novus Biologicals
- 11.12.1 Novus Biologicals Company Information
- 11.12.2 Novus Biologicals Research Grade Antibodies Product Offered
- 11.12.3 Novus Biologicals Research Grade Antibodies Revenue, Gross Margin and Market Share (2020-2022)
- 11.12.4 Novus Biologicals Main Business Overview
- 11.12.5 Novus Biologicals Latest Developments
- 11.13 Genetex
- 11.13.1 Genetex Company Information
- 11.13.2 Genetex Research Grade Antibodies Product Offered
- 11.13.3 Genetex Research Grade Antibodies Revenue, Gross Margin and Market Share (2020-2022)
- 11.13.4 Genetex Main Business Overview
- 11.13.5 Genetex Latest Developments
- 11.14 Abnova
- 11.14.1 Abnova Company Information
- 11.14.2 Abnova Research Grade Antibodies Product Offered
- 11.14.3 Abnova Research Grade Antibodies Revenue, Gross Margin and Market Share (2020-2022)
- 11.14.4 Abnova Main Business Overview
- 11.14.5 Abnova Latest Developments
- 11.15 Abcepta
- 11.15.1 Abcepta Company Information
- 11.15.2 Abcepta Research Grade Antibodies Product Offered
- 11.15.3 Abcepta Research Grade Antibodies Revenue, Gross Margin and Market Share (2020-2022)
- 11.15.4 Abcepta Main Business Overview
- 11.15.5 Abcepta Latest Developments
- 11.16 Aviva Biosciences
- 11.16.1 Aviva Biosciences Company Information
- 11.16.2 Aviva Biosciences Research Grade Antibodies Product Offered
- 11.16.3 Aviva Biosciences Research Grade Antibodies Revenue, Gross Margin and Market Share (2020-2022)
- 11.16.4 Aviva Biosciences Main Business Overview
- 11.16.5 Aviva Biosciences Latest Developments
- 11.17 MBL
- 11.17.1 MBL Company Information
- 11.17.2 MBL Research Grade Antibodies Product Offered
- 11.17.3 MBL Research Grade Antibodies Revenue, Gross Margin and Market Share (2020-2022)
- 11.17.4 MBL Main Business Overview
- 11.17.5 MBL Latest Developments
- 11.18 BioXCell
- 11.18.1 BioXCell Company Information
- 11.18.2 BioXCell Research Grade Antibodies Product Offered
- 11.18.3 BioXCell Research Grade Antibodies Revenue, Gross Margin and Market Share (2020-2022)
- 11.18.4 BioXCell Main Business Overview
- 11.18.5 BioXCell Latest Developments
- 11.19 Sino Biological
- 11.19.1 Sino Biological Company Information
- 11.19.2 Sino Biological Research Grade Antibodies Product Offered
- 11.19.3 Sino Biological Research Grade Antibodies Revenue, Gross Margin and Market Share (2020-2022)
- 11.19.4 Sino Biological Main Business Overview
- 11.19.5 Sino Biological Latest Developments
- 11.20 HuaBio
- 11.20.1 HuaBio Company Information
- 11.20.2 HuaBio Research Grade Antibodies Product Offered
- 11.20.3 HuaBio Research Grade Antibodies Revenue, Gross Margin and Market Share (2020-2022)
- 11.20.4 HuaBio Main Business Overview
- 11.20.5 HuaBio Latest Developments
12 Research Findings and Conclusion
Summary:
Get latest Market Research Reports on Research Grade Antibodies . Industry analysis & Market Report on Research Grade Antibodies is a syndicated market report, published as Global Research Grade Antibodies Market Growth (Status and Outlook) 2022-2028. It is complete Research Study and Industry Analysis of Research Grade Antibodies market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
